Home » Prices » NYSE:DHR

Danaher Corporation NYSE:DHR

Today's live share price, quote history, chart & news

Price:
158.26 USD
Change:
+0.6 (0.38%)
Key Stats
Price open 157.76
Previous close 157.66
Market cap 111.89B
Volume 1.48M
Day high 158.68
Day low 156.52
Year high 170.64
Year low 119.6
Year to date change 3.17%
P/E Ratio 41.20
Company Profile
Fundamentals
Insider Information
News

About Danaher Corporation

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Company information

Company name
Danaher Corp.
Exchange
Sector
Health Technology
Industry
Medical Specialties
Employees
60,000
CEO
Thomas Patrick Joyce
Address
2200 Pennsylvania Avenue NW, Washington, DC, 20037-1701
Country
United States
Contact information
1.202.828.0850
Website
http://www.danaher.com

Related companies

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.